| Autor: |
Cafardi JM; The Christ Hospital and The University of Cincinnati Medical Center, USA., Sami N; Department of Dermatology, The University of Alabama at Birmingham, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
The open rheumatology journal [Open Rheumatol J] 2015 Nov 04; Vol. 9, pp. 77-81. Date of Electronic Publication: 2015 Nov 04 (Print Publication: 2015). |
| DOI: |
10.2174/1874312901409010077 |
| Abstrakt: |
Amyopathic dermatomyositis (ADM) is a rare subtype of dermatomyositis which is often recalcitrant to immune suppressing treatments. Intravenous immunoglobulin (IVIG) has been used in the treatment of refractory dermatomyositis. We present two patients with severe ADM, who were treated with IVIG at 2 g/kg every four weeks. Both patients had a successful response and were able to taper the dosage of prednisone. We present both cases in describing IVIG as a rescue and maintenance steroid-sparing agent in the treatment of severe refractory ADM. We also review the treatment of refractory ADM with IVIg in the English literature. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
